×

Cramer reviews the bull and bear cases for medical device maker BioTelemetry

4:10 PM ET Wed, 27 Sept 2017

Jim Cramer goes over Wall Street coverage of cardiac monitoring company BioTelemetry and explains why he'd stick with the bull case.